• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO

cafead

Administrator
Staff member
  • cafead   May 26, 2021 at 11:33: AM
via Preclinical biotech Lyell Immunopharma is looking to go public after a whirlwind year of big deals and big bucks raises as it looks to use cell therapy to beat solid tumors.

article source
 

<